Bio Impact Capital LLC Werewolf Therapeutics, Inc. Put Options Transaction History
Bio Impact Capital LLC
- $611 Million
- Q1 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding HOWL
# of Institutions
65Shares Held
26.1MCall Options Held
2.4KPut Options Held
35K-
Mpm Asset Management LLC Cambridge, MA4.28MShares$9.34 Million11.32% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.01MShares$6.55 Million0.96% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3MShares$6.54 Million0.04% of portfolio
-
Bank Of America Corp Charlotte, NC1.88MShares$4.1 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.69MShares$3.68 Million0.01% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $64.4M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...